Although decreased ST6Gal1 may increase EGF-induced activation of EGFR and ERK1/2 in CRC cells [93], NDAT was shown to inhibit the phosphorylation of ERK1/2 and the accumulation of ST6Gal1 in CRC cells [33]. Here, ST6GAL1 is linked to colorectal carcinoma.